OPGEN
Headquartered in Rockville, Maryland, OpGen (NASDAQ:OPGN) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes. Our innovative approaches to infectious disease diagno... stics consist of highly multiplexed syndromic molecular panels, and next-generation sequencing combined with smart bioinformatics and artificial intelligence to address the global threat of antimicrobial resistance (AMR). By integrating these capabilities, we provide unique rapid molecular diagnostic products and services that help to dramatically transform patient care by using precision medicine to guide antibiotic therapy selection and optimize the treatment of life-threatening drug-resistant infections, improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). OpGen Community (Linkedin Group) provides an accessible environment to share information, exchange questions and best practices using OpGenโs technologies in a variety of applications.
OPGEN
Industry:
Biotechnology Genetics Health Care
Founded:
2002-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.opgen.com
Total Employee:
101+
Status:
Active
Contact:
+3018699683
Email Addresses:
[email protected]
Total Funding:
158.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Color
Color is a complete platform for healthcare delivery.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2015-07-14 | AdvanDx | AdvanDx acquired by OpGen | N/A |
Investors List
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Post-IPO Equity - OpGen
Sabby Management
Sabby Management investment in Post-IPO Equity - OpGen
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Post-IPO Equity - OpGen
180 Degree Capital
180 Degree Capital investment in Series C - OpGen
CHL Medical Partners
CHL Medical Partners investment in Series C - OpGen
jVen Capital
jVen Capital investment in Series C - OpGen
Versant Ventures
Versant Ventures investment in Series C - OpGen
Highland Capital Partners
Highland Capital Partners investment in Series C - OpGen
Cross Creek
Cross Creek investment in Series C - OpGen
Mason Wells
Mason Wells investment in Series B - OpGen
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2012-03-22 | BioRelix | OpGen investment in Venture Round - BioRelix | 2.56 M USD |
Key Employee Changes
Date | New article |
---|---|
2021-11-04 | OpGen Appoints Albert Weber as Chief Financial Officer |
Official Site Inspections
http://www.opgen.com Semrush global rank: 4.52 M Semrush visits lastest month: 2.35 K
- Host name: 49.122.212.35.bc.googleusercontent.com
- IP address: 35.212.122.49
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York